In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Data Quality Workshops during four conferences in 2017. During these workshops, conference attendees had the opportunity to voice their opinions on the state of UDI data quality, hurdles to UDI adoption and what recommended practices are necessary for providers and suppliers to effectively capture the UDI and use it in meaningful ways.
Filter your results:
5 Results Found
The Critical Link Between Cost, Quality, and Outcomes (CQO) and Unique Device Identification (UDI) White Paper
In 2014, AHRMM hosted the first Cost, Quality, and Outcomes (CQO) Summit to bring healthcare thought leaders together and discuss particular supply chain issues and concerns. The results of those conversations were used to develop the first task force and to shape the agenda for the second CQO Summit, held in 2015.
The Purpose of this white paper is to prepare Supply Chain professionals to better understand how to support navigating some of the risks and opportunities inherent in participating in the 340B Drug Discount Program.
This paper provides a case-study on what Banner has done to implement and continuously improve this initiative. Three key components to successful supply utilization savings are reviewed.
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the supply chain. Download Now